Key result
Olanzapine overdose presents with marked sinus bradycardia without QT prolongation, resolving with supportive care.
Why the study?
Olanzapine overdose is typically associated with tachycardia and QT prolongation, whereas bradycardia remains a rare and underrecognized effect.
Olanzapine overdose can present with isolated, marked sinus bradycardia that resolves completely with supportive care, highlighting an uncommon but important cardiovascular toxicity.
Answers are grounded in this paper and cite their sources.
Alerts to possible bradycardia in olanzapine overdose; challenges typical tachycardia/QT profile but hypothesis-generating.
Olanzapine, an atypical antipsychotic widely used for psychiatric disorders, is typically associated with tachycardia and QT prolongation in overdose, while bradycardia remains a rare and underrecognized effect. We report a 20‐year‐old woman with major depressive disorder who presented 4 h after ingesting 100 mg of olanzapine in a suicide attempt. She exhibited marked sinus bradycardia (41 bpm) with stable hemodynamics and no QT prolongation. Laboratory and toxicology results were unremarkable. Supportive care, including oxygen, fluids, and cardiac monitoring, led to complete recovery within 48 h. This case highlights isolated bradycardia as an uncommon but important manifestation of olanzapine toxicity. Clinicians should consider bradycardia in the cardiovascular spectrum of olanzapine overdose and ensure vigilant monitoring to prevent potential complications.
No takes yet. Share an insight, caveat, or question.
Palangi et al. (2026) studied this question. A olanzapine overdose caused marked sinus bradycardia (41 bpm) without QT prolongation in a young adult, resolving with supportive care within 48 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: